These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1622121)
21. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792 [TBL] [Abstract][Full Text] [Related]
22. alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A. Greenberger LM; Collins KI; Annable T; Boni JP; May MK; Lai FM; Kramer R; Citeralla RV; Hallett WA; Powell D Oncol Res; 1996; 8(5):207-18. PubMed ID: 8884813 [TBL] [Abstract][Full Text] [Related]
23. Acquired vs innate multidrug resistance and the effect of calcium channel blockers. Tsuruo T Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells. Tatsuta T; Shimizu K; Nishimura T; Suzuki H Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605 [TBL] [Abstract][Full Text] [Related]
25. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931 [TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359 [TBL] [Abstract][Full Text] [Related]
27. Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells. Safa AR; Roberts S; Agresti M; Fine RL Biochem Biophys Res Commun; 1994 Jul; 202(1):606-12. PubMed ID: 7913604 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855 [TBL] [Abstract][Full Text] [Related]
29. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Kavallaris M; Madafiglio J; Norris MD; Haber M Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660 [TBL] [Abstract][Full Text] [Related]
30. Multiform combination effects of smooth muscle relaxants with antitumor agents in rat ascites hepatoma AH66 cells. Takagi K; Satake T; Hasegawa T; Miyamoto K; Wakusawa S; Matsunaga T; Koshiura R Jpn J Pharmacol; 1987 Sep; 45(1):69-77. PubMed ID: 2824896 [TBL] [Abstract][Full Text] [Related]
31. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Qian XD; Beck WT Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551 [TBL] [Abstract][Full Text] [Related]
32. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Nare B; Prichard RK; Georges E Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815 [TBL] [Abstract][Full Text] [Related]
33. Selective modulation of P-glycoprotein-mediated drug resistance. Bebawy M; Morris MB; Roufogalis BD Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345 [TBL] [Abstract][Full Text] [Related]
34. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone). Weber JM; Sircar S; Horvath J; Dion P Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of natural resistance to vincristine in rat ascites hepatoma AH66. Inaba M; Takayama K; Sakurai Y Gan; 1981 Aug; 72(4):562-8. PubMed ID: 7308668 [TBL] [Abstract][Full Text] [Related]
36. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression. Slapak CA; Daniel JC; Levy SB Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251 [TBL] [Abstract][Full Text] [Related]
37. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis. Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512 [TBL] [Abstract][Full Text] [Related]
38. In vivo cisplatin resistance of rat ascites hepatoma AH66. Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588 [TBL] [Abstract][Full Text] [Related]
39. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells. Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849 [TBL] [Abstract][Full Text] [Related]
40. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. Safa AR; Glover CJ; Meyers MB; Biedler JL; Felsted RL J Biol Chem; 1986 May; 261(14):6137-40. PubMed ID: 3700389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]